Literature DB >> 9161814

Vanadium-mediated chemoprotection against chemical hepatocarcinogenesis in rats: haematological and histological characteristics.

A Bishayee1, R Karmakar, A Mandal, S N Kundu, M Chatterjee.   

Abstract

The trace element vanadium was investigated for its anti-neoplastic role in relation to haematological status, hepatic histopathology and histochemical analysis of glycogen in liver. Its impact on the survival of male Sprague-Dawley rats subjected to a two-stage hepatocarcinogenesis regimen was also assessed. Initiation was performed using a single intraperitoneal injection of diethylnitrosamine (DENA) (200 mg/kg) followed by promotion with phenobarbital (0.05%) in a basal diet. Vanadium supplementation as ammonium monovanadate at 0.5 ppm vanadium in drinking water was given ad libitum throughout the experiment (20 weeks), before the initiation (4 weeks), or during the promotional period (14 weeks). At the end of the study, there was a significant decrease in red blood cell count, haemoglobin content, haematocrit value, mean corpuscular haemoglobin, mean corpuscular haemoglobin concentration, plasma volume change and total white cell count, with a concurrent alteration in lymphoid:myeloid ratio in DENA control animals compared with their normal counterparts. Vanadium supplementation throughout the study or before the initiation significantly reversed the DENA-induced alterations in most of the haematological indices. A single intraperitoneal injection of DENA also depleted the plasma albumin concentration, raised the plasma globulin content, and decreased the ratio of albumin to globulin. These altered features began to return to normal following vanadium supplementation. Supplementary vanadium also elicited substantial protection against DENA-mediated rat liver carcinogenesis. This was fairly evident from hepatic histology and evaluation of glycogen accumulation by periodic acid-Schiff reaction. The survival of DENA-treated animals was considerably increased in the presence of vanadium. The critical involvement of vanadium in modulating several factors associated with erythropoiesis under carcinogenic challenge may thus have a possible impact on the eventual increased survival of the host.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9161814     DOI: 10.1097/00008469-199702000-00010

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  7 in total

1.  Chemopreventive effect of vanadium in a rodent model of chemical hepatocarcinogenesis: reflections in oxidative DNA damage, energy-dispersive X-ray fluorescence profile and metallothionein expression.

Authors:  Tridib Chakraborty; Amrita Chatterjee; Mahesh G Saralaya; Malay Chatterjee
Journal:  J Biol Inorg Chem       Date:  2006-07-08       Impact factor: 3.358

2.  Inhibition of DNA alkylation damage with inorganic salts.

Authors:  Elizabeth E Hamilton; Jonathan J Wilker
Journal:  J Biol Inorg Chem       Date:  2004-09-16       Impact factor: 3.358

3.  (E)-N'-{7-Meth-oxy-spiro-[chromeno[4,3-d]thia-zole-4,1'-cyclo-hexa-n]-2-yl}-N,N-dimethyl-acetimidamide.

Authors:  Kamini Kapoor; Vivek K Gupta; Rajni Kant; Poorvesh M Vyas; Mihir J Joshi; Kalpesh M Menpara; Kartik D Ladva
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-10-05

4.  1-(5-Bromo-4-phenyl-1,3-thia-zol-2-yl)pyrrolidin-2-one.

Authors:  Hazem A Ghabbour; Adnan A Kadi; Hussein I El-Subbagh; Tze Shyang Chia; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-05-16

5.  [2-(Biphenyl-4-yl)-1,3-thia-zol-4-yl]methanol.

Authors:  Manpreet Kaur; Jerry P Jasinski; Amanda C Keeley; H S Yathirajan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-09-19

6.  Magnesium can protect against vanadium-induced lipid peroxidation in the hepatic tissue.

Authors:  Agnieszka Scibior; Dorota Gołębiowska; Irmina Niedźwiecka
Journal:  Oxid Med Cell Longev       Date:  2013-05-13       Impact factor: 6.543

7.  Vanadium complex: an appropriate candidate for killing hepatocellular carcinoma cancerous cells.

Authors:  Hamid Bakhshi Aliabad; Soudeh Khanamani Falahati-Pour; Hadis Ahmadirad; Maryam Mohamadi; Mohammad Reza Hajizadeh; Mehdi Mahmoodi
Journal:  Biometals       Date:  2018-09-25       Impact factor: 2.949

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.